Abstract
This short report is dedicated to the description of the wide antiviral and antibacterial activity of the immune-modulating agent Panavir®. Panavir® is a high-molecular-weight fraction of the polysaccharides extracted from the shoots of the Solanum tuberosum. It demonstrates activity against many types of viruses, including animal coronavirus and also against bacterial infections. These properties look very promising considering the COVID-19 epidemy and allow propose that Panavir® would be effective in the therapy of the SARS-CoV-2 infection.
Keywords:
Antiviral activity; COVID-19; Immune modulator.
Copyright © 2020 Elsevier B.V. All rights reserved.
MeSH terms
-
Adult
-
Animals
-
Antiviral Agents / chemistry
-
Antiviral Agents / pharmacology*
-
Antiviral Agents / therapeutic use
-
Betacoronavirus / drug effects
-
COVID-19
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / virology
-
Disease Models, Animal
-
Dysentery, Bacillary / drug therapy
-
Female
-
Glycosides / chemistry
-
Glycosides / pharmacology*
-
Glycosides / therapeutic use
-
Herpes Genitalis / drug therapy*
-
Humans
-
Klebsiella Infections / drug therapy
-
Klebsiella pneumoniae / drug effects
-
Male
-
Mice
-
Middle Aged
-
Pandemics
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / virology
-
SARS-CoV-2
-
Shigella flexneri / drug effects
-
Young Adult
Substances
-
Antiviral Agents
-
Glycosides
-
Panavir (Solanum tuberosum)